Spectrum Pharmaceuticals, Inc. Gets FDA OK on Investigational Drug

Shares of Spectrum Pharmaceuticals, Inc. got a boost after the biopharmaceutical company announced that the U.S. Food and Drug Administration has cleared its investigational new drug application for the use of SPI-1620 in patients with recurrent or progressive carcinoma.
Small Cap Investor